News Foley Represents TCGX as Co-Lead Investor in $150M Series B Financing for Alkeus Pharmaceuticals Foley & Lardner LLP represented TCGX as co-lead investor in the $150 million Series B…Louis LehotJanuary 23, 2024
News Foley Represents NEA as Lead Investor in Comanche Biopharma Series B Round Foley & Lardner LLP recently represented New Enterprise Associates, Inc. (NEA) as lead investor in…Louis LehotJanuary 18, 2024
News Foley Represents TDK Ventures as Investor in Infinite Uptime Foley & Lardner LLP represented TDK Ventures as an investor in Infinite Uptime, the Industry…Louis LehotJanuary 17, 2024
News Foley Represents NEA as Investor in Series B Round for Fizz Foley & Lardner LLP represented New Enterprise Associates, Inc. (NEA) as co-lead investor in the…Louis LehotJanuary 16, 2024
News Foley Represents NEA as Co-Lead Investor in Funding Round for Orby AI Foley & Lardner LLP represented NEA as co-lead investor in the latest funding round for…Louis LehotJanuary 12, 2024
News Foley Represents Customer Fulfillment Robotics Company Instock in Latest Funding Round Foley & Lardner LLP recently represented Instock Inc., an innovator in customer fulfillment robotics, in…Louis LehotJanuary 11, 2024
News Louis Lehot Quoted on Health Care & Life Sciences Dealmaking Outlook Foley & Lardner LLP partner Louis Lehot is quoted in the Law360 article, “Attys Hopeful For Deals…Louis LehotJanuary 5, 2024
News Foley Represents TDK Ventures as Lead Investor in Series A Funding Round for Faction Technology Foley & Lardner LLP represented TDK Ventures as the lead investor in the Series A…Louis LehotJanuary 5, 2024
News Foley Represents Envisioning Partners as Lead Investor in Series A Funding for Dimensional Energy Foley & Lardner LLP represented Envisioning Partners as the lead investor in the Series A…Louis LehotJanuary 4, 2024
News Foley Serves as Legal Adviser to knownwell in $20M Series A Funding Foley & Lardner LLP served as legal adviser to knownwell, an in-person and virtual weight-inclusive…Von BryantDecember 21, 2023